HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical characteristics of the thyroid follicular carcinoma].

AbstractBACKGROUND:
the prevalence of thyroid follicular carcinoma (TFC) is 39 % in patients with an undetermined histological diagnosis. The aim was to know the prevalence of TFC in a hospital with high population concentration.
METHODS:
surgical reports with a final diagnosis of TFC were reviewed. The size of the tumor, age, gender, pre- and post-surgical diagnosis and comorbidities were retrieved.
RESULTS:
a total of 35 reports with a diagnosis of TFC were found: 30 (85 %) were females with a mean age 44 ± 16.9 years. The mean age was 57 ± 6.6 in males. The diagnoses before surgery were follicular carcinoma 14 (40 %), thyroid cancer 6 (17.1 %), thyroid adenoma 4 (11.4 %), goiter 3 (8.5 %), thyroid nodule 3 (8.5 %), one papillary carcinoma (2.8 %), one thyroid neoplasm (2.8 %), one poorly differentiated adenocarcinoma (2.8 %), one well differentiated follicular adenocarcinoma (2.8 %), and one medullary thyroid cancer (2.8 %). The comorbidities found were Hashimoto disease 2 (5.6 %) and papillary contralateral carcinoma 2 patients (5.6 %).
CONCLUSIONS:
follicular carcinomas of the thyroid of our population differ in clinical presentation compared with previous reports.
AuthorsHugo Gutiérrez-Hermosillo, Héctor Eloy Tamez-Peréz, Enrique Díaz de León-Gonzaléz, Violeta Gutiérrez-Hermosillo, Jair Avila-Sanchéz
JournalRevista medica del Instituto Mexicano del Seguro Social (Rev Med Inst Mex Seguro Soc) Vol. 51 Issue 2 Pg. 188-91 ( 2013) ISSN: 2448-5667 [Electronic] Mexico
Vernacular TitleCaracterísticas clínicas del carcinoma folicular de tiroides.
PMID23693108 (Publication Type: English Abstract, Journal Article)
Topics
  • Adenocarcinoma, Follicular (diagnosis, epidemiology)
  • Adult
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Thyroid Neoplasms (diagnosis, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: